These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 8324152

  • 1. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
    Bandoh K, Ueno K, Watanabe K, Kato N.
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K, Kato N, Watanabe K, Ueno K.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 5. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
    Fernández-Canigia L, Litterio M, Legaria MC, Castello L, Predari SC, Di Martino A, Rossetti A, Rollet R, Carloni G, Bianchini H, Cejas D, Radice M, Gutkind G, Anaerobe Surveillance Team.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
    [Abstract] [Full Text] [Related]

  • 6. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.
    Hurlbut S, Cuchural GJ, Tally FP.
    Antimicrob Agents Chemother; 1990 Jan; 34(1):117-20. PubMed ID: 2327745
    [Abstract] [Full Text] [Related]

  • 7. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
    Appelbaum PC, Spangler SK, Jacobs MR.
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Aug; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
    Appelbaum PC, Spangler SK, Jacobs MR.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J, Lee Y, Kim M, Seo YH, Kim WH, Yong D, Jeong SH, Lee K, Chong Y.
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 17. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
    Snydman DR, McDermott L, Cuchural GJ, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
    [Abstract] [Full Text] [Related]

  • 18. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance.
    Yamazoe K, Kato N, Kato H, Tanaka K, Katagiri Y, Watanabe K.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2808-10. PubMed ID: 10543771
    [Abstract] [Full Text] [Related]

  • 19. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH, Kim S, Kim CK, Yum JH, Kim MS, Yong D, Lee K, Kim JM, Chong Y.
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [Abstract] [Full Text] [Related]

  • 20. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
    das Graças Silva E Souza W, Avelar KE, Antunes LC, Lobo LA, Domingues RM, de Souza Ferreira MC.
    J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.